A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)

NCT01174355 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit and Hyperactivity Disorder

Interventions

DRUG: ND0801

Sponsor

NeuroDerm Ltd.